Return On Assets of CNS Pharmaceuticals, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CNS Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • CNS Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -107%, a 79% increase year-over-year.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2024 was -294%, a 30% increase from 2023.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2023 was -421%, a 252% decline from 2022.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2022 was -120%, a 1.6% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CNS Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -107% +408% +79% 01 Jul 2025 30 Sep 2025
Q2 2025 -139% +644% +82% 01 Apr 2025 30 Jun 2025
Q1 2025 -193% +382% +66% 01 Jan 2025 31 Mar 2025
Q4 2024 -294% +128% +30% 01 Oct 2024 31 Dec 2024
Q3 2024 -515% -261% -102% 01 Jul 2024 30 Sep 2024
Q2 2024 -783% -592% -309% 01 Apr 2024 30 Jun 2024
Q1 2024 -575% -415% -259% 01 Jan 2024 31 Mar 2024
Q4 2023 -421% -302% -252% 01 Oct 2023 31 Dec 2023
Q3 2023 -255% -140% -122% 01 Jul 2023 30 Sep 2023
Q2 2023 -192% -78% -69% 01 Apr 2023 30 Jun 2023
Q1 2023 -160% -49% -44% 01 Jan 2023 31 Mar 2023
Q4 2022 -120% +2% +1.6% 01 Oct 2022 31 Dec 2022
Q3 2022 -115% -11% -10% 01 Jul 2022 30 Sep 2022
Q2 2022 -114% -6% -5.4% 01 Apr 2022 30 Jun 2022
Q1 2022 -111% +12% +9.8% 01 Jan 2022 31 Mar 2022
Q4 2021 -122% +9% +6.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -104% +66% +39% 01 Jul 2021 30 Sep 2021
Q2 2021 -108% +50% +32% 01 Apr 2021 30 Jun 2021
Q1 2021 -123% 01 Jan 2021 31 Mar 2021
Q4 2020 -130% 01 Oct 2020 31 Dec 2020
Q3 2020 -170% 01 Jul 2020 30 Sep 2020
Q2 2020 -157% 01 Apr 2020 30 Jun 2020

CNS Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -294% +128% +30% 01 Jan 2024 31 Dec 2024
2023 -421% -302% -252% 01 Jan 2023 31 Dec 2023
2022 -120% +2% +1.6% 01 Jan 2022 31 Dec 2022
2021 -122% +9% +6.6% 01 Jan 2021 31 Dec 2021
2020 -130% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.